Hospira announced a voluntary recall of various lots of several intravenous (IV) solutions in its LifeCare line due to potential for leakage.
Early season influenza vaccination of patients with HIV may influence the risk of infection later in the season.
Starting this week, the Centers for Disease Control and Prevention (CDC) and the Department of Homeland Security's Customs & Border Protection (CBP) will initiate new layers of entry screening in five U.S. airports that receive over 94% of travelers from Ebola-affected nations of Guinea, Liberia, and Sierra Leone.
Hospira announced a voluntary recall of one lot of Vancomycin HCl Injection, equivalent to 1g Vancomycin Sterile Powder because the product may have experienced temperature excursions during shipment.
Gilead Sciences announced that the Food and Drug Administration (FDA) has approved Harvoni (ledipasvir/sofosbuvir), the first once-daily single tablet regimen for the treatment of chronic hepatitis C genotype 1 infection in adults ages ≥18.
Twenty-nine states and the District of Columbia now have a total of 213 confirmed cases of Enterovirus D68, the severe respiratory illness that typically targets children, U.S. health officials are reporting.
T2 Biosystems announced that it has received marketing clearance from the Food and Drug Administration (FDA) for their T2Candida Panel and T2Dx Instrumeny.